Citadel Advisors »

Protagonist Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Protagonist Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protagonist Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protagonist Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $10M 446k 22.93
2023-09-30 $6.8M 407k 16.68
2023-06-30 $27M 975k 27.62
2023-03-31 $38M 1.6M 23.00
2022-12-31 $30M 2.7M 10.91
2022-06-30 $5.2M 657k 7.86
2022-03-31 $8.5M 361k 23.68
2021-12-31 $5.0M 147k 34.21
2021-09-30 $7.6M 427k 17.73
2021-06-30 $19M 430k 44.89
2021-03-31 $5.4M 208k 25.90
2020-12-31 $6.9M 341k 20.17
2020-03-31 $3.3M 469k 7.06
2019-12-31 $3.2M 459k 7.05
2019-09-30 $5.0M 416k 12.01
2019-06-30 $5.0M 410k 12.11
2019-03-31 $4.6M 364k 12.57
2018-12-31 $234k 35k 6.73
2018-09-30 $368k 36k 10.29
2018-06-30 $883k 131k 6.72
2018-03-31 $423k 49k 8.60